Potential role of genetic markers in the management of kidney cancer

European Urology

Volumn 63, Issue 2, 2013, Pages 333-340

  Junker, Kerstin ^a   Ficarra, Vincenzo ^b   Kwon, Eugene D ^c,d   Leibovich, Bradley C ^c   Thompson, R Houston ^c   Oosterwijk, Egbert ^e  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF PADOVA   (Italy)

^c Mayo Clinic   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gene expression; Genetic markers; Kidney cancer

Indexed keywords

ALPHA INTERFERON; AXITINIB; BEVACIZUMAB; EVEROLIMUS; MICRORNA; PAZOPANIB; SORAFENIB; SUNITINIB;

CANCER DIAGNOSIS; CANCER GENETICS; CANCER PROGNOSIS; CANCER THERAPY; DNA METHYLATION; DRUG TARGETING; ENZYME METABOLISM; EPIGENETICS; GENE EXPRESSION; GENE SEQUENCE; GENETIC MARKER; GENETIC POLYMORPHISM; HUMAN; KIDNEY CANCER; KIDNEY CARCINOMA; MEDLINE; MOLECULAR PATHOLOGY; NONHUMAN; PEER REVIEW; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; VALIDATION STUDY;

ADENOMA, OXYPHILIC; CARCINOMA, RENAL CELL; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; KIDNEY NEOPLASMS; MOLECULAR TARGETED THERAPY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 84871920078     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.09.040     Document Type: Review

References (69)

1. K. Gupta, J.D. Miller, J.Z. Li, M.W. Russell, and C. Charbonneau Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review Cancer Treat Rev 34 2008 193 205
2. W. Thoenes, S. Storkel, and H.J. Rumpelt Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics Pathol Res Pract 181 1986 125 143 (Pubitemid 16021498)
3. E. van den Berg, and T. Dijkhuizen Classification of renal cell cancer based on (cyto)genetic analysis Contrib Nephrol 128 1999 51 61
4. K. Junker, G. Weirich, M.B. Amin, P. Moravek, W. Hindermann, and J. Schubert Genetic subtyping of renal cell carcinoma by comparative genomic hybridization Recent Results Cancer Res 162 2003 169 175
5. F. Latif, K. Tory, and J. Gnarra Identification of the von Hippel-Lindau disease tumor suppressor gene Science 260 1993 1317 1320 (Pubitemid 23231974)
6. G. Kovacs, L. Fuzesi, A. Emanual, and H.F. Kung Cytogenetics of papillary renal cell tumors Genes Chromosomes Cancer 3 1991 249 255
7. X.J. Yang, M.H. Tan, and H.L. Kim A molecular classification of papillary renal cell carcinoma Cancer Res 65 2005 5628 5637 (Pubitemid 40911163)
8. T. Klatte, A.J. Pantuck, and J.W. Said Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma Clin Cancer Res 15 2009 1162 1169
9. B. Gunawan, A. von Heydebreck, and T. Fritsch Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors Cancer Res 63 2003 6200 6205 (Pubitemid 37255164)
10. F.A. Monzon, J.M. Hagenkord, and M.A. Lyons-Weiler Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors Mod Pathol 21 2008 599 608 (Pubitemid 351589654)
11. M.I. Toma, M. Grosser, and A. Herr Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array Neoplasia 10 2008 634 642 (Pubitemid 351883879)
12. J. Sanjmyatav, N. Rubtsov, H. Starke, J. Schubert, W. Hindermann, and K. Junker Identification of tumor entities of renal cell carcinoma using interphase fluorescence in situ hybridization J Urol 174 2005 731 735 (Pubitemid 40981645)
13. M. Brunelli, B. Delahunt, and S. Gobbo Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses Am J Clin Pathol 133 2010 116 126
14. M. Brunelli, D. Segala, and B. Delahunt FISH scoring on paraffin sections versus single-cell suspension for chromophobe renal carcinoma and renal oncocytoma Anticancer Res 31 2011 3137 3142
15. M. Dvorakova, R. Dhir, and S.I. Bastacky Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up Diagn Pathol 5 2010 32
16. J. Vieira, R. Henrique, and F.R. Ribeiro Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies Genes Chromosomes Cancer 49 2010 935 947
17. D.A. Barocas, S.M. Rohan, and J. Kao Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis J Urol 176 2006 1957 1962 (Pubitemid 44633153)
18. A. Chyhrai, J. Sanjmyatav, and M. Gajda Multi-colour FISH on preoperative renal tumour biopsies to confirm the diagnosis of uncertain renal masses World J Urol 28 2010 269 274
19. J.M. Mosquera, P. Dal Cin, and K.D. Mertz Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas Diagn Mol Pathol 20 2011 129 137
20. M. Zhong, P. De Angelo, and L. Osborne Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma Am J Surg Pathol 34 2010 757 766
21. J.M. Boer, W.K. Huber, and H. Sultmann Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array Genome Res 11 2001 1861 1870 (Pubitemid 33100427)
22. J.P. Higgins, R. Shinghal, and H. Gill Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray Am J Pathol 162 2003 925 932 (Pubitemid 36237499)
23. M. Takahashi, X.J. Yang, and J. Sugimura Molecular subclassification of kidney tumors and the discovery of new diagnostic markers Oncogene 22 2003 6810 6818 (Pubitemid 37372221)
24. A.N. Young, M.B. Amin, and C.S. Moreno Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers Am J Pathol 158 2001 1639 1651 (Pubitemid 32422929)
25. S.T. Chuang, P. Chu, and J. Sugimura Overexpression of glutathione s-transferase alpha in clear cell renal cell carcinoma Am J Clin Pathol 123 2005 421 429 (Pubitemid 40315084)
26. M.S. Tretiakova, S. Sahoo, and M. Takahashi Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma Am J Surg Pathol 28 2004 69 76 (Pubitemid 38031623)
27. Y. Allory, C. Bazille, and A. Vieillefond Profiling and classification tree applied to renal epithelial tumours Histopathology 52 2008 158 166
28. H.S. Stafford, S.L. Saltzstein, S. Shimasaki, C. Sanders, T.M. Downs, and G.R. Sadler Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival J Urol 179 2008 1704 1708
29. I. Sekine, N. Yamamoto, K. Nishio, and N. Saijo Emerging ethnic differences in lung cancer therapy Br J Cancer 99 2008 1757 1762
30. H. Uemura, N. Shinohara, and T. Yuasa A phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma: insights into the treatment, efficacy and safety Jpn J Clin Oncol 40 2010 194 202
31. G.L. Dalgliesh, K. Furge, and C. Greenman Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes Nature 463 2010 360 363
32. X. Xu, Y. Hou, and X. Yin Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor Cell 148 2012 886 895
33. M. Gerlinger, A.J. Rowan, and S. Horswell Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N Engl J Med 366 2012 883 892
34. I. Varela, P. Tarpey, and K. Raine Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma Nature 469 2011 539 542
35. M.R. Morris, C.J. Ricketts, and D. Gentle Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma Oncogene 30 2011 1390 1401
36. E. Arai, S. Wakai-Ushijima, and H. Fujimoto Genome-wide DNA methylation profiles in renal tumors of various histological subtypes and non-tumorous renal tissues Pathobiology 78 2011 1 9
37. F. Gottardo, C.G. Liu, and M. Ferracin Micro-RNA profiling in kidney and bladder cancers Urol Oncol 25 2007 387 392 (Pubitemid 47362758)
38. D. Juan, G. Alexe, and T. Antes Identification of a microRNA panel for clear-cell kidney cancer Urology 75 2010 835 841
39. Y.M. Youssef, N.M. White, and J. Grigull Accurate molecular classification of kidney cancer subtypes using microRNA signature Eur Urol 59 2011 721 730
40. D. Petillo, E.J. Kort, J. Anema, K.A. Furge, X.J. Yang, and B.T. Teh MicroRNA profiling of human kidney cancer subtypes Int J Oncol 35 2009 109 114
41. M.P. Powers, K. Alvarez, H.J. Kim, and F.A. Monzon Molecular classification of adult renal epithelial neoplasms using microRNA expression and virtual karyotyping Diagn Mol Pathol 20 2011 63 70
42. R.A. Perego, M. Corizzato, and P. Brambilla Concentration and microsatellite status of plasma DNA for monitoring patients with renal carcinoma Eur J Cancer 44 2008 1039 1047
43. R. von Knobloch, A. Hegele, and H. Brandt High frequency of serum DNA alterations in renal cell carcinoma detected by fluorescent microsatellite analysis Int J Cancer 98 2002 889 894 (Pubitemid 34286686)
44. F. Gang, L. Guorong, Z. An, G.P. Anne, G. Christian, and T. Jacques Prediction of clear cell renal cell carcinoma by integrity of cell-free DNA in serum Urology 75 2010 262 265
45. M. de Martino, T. Klatte, A. Haitel, and M. Marberger Serum cell-free DNA in renal cell carcinoma: a diagnostic and prognostic marker Cancer 118 2012 82 90
46. L.M. Wulfken, R. Moritz, and C. Ohlmann MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels PLoS One 6 2011 e25787
47. J.C. Cheville, C.M. Lohse, H. Zincke, A.L. Weaver, and M.L. Blute Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma Am J Surg Pathol 27 2003 612 624 (Pubitemid 36514472)
48. J.J. Patard, E. Leray, and N. Rioux-Leclercq Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience J Clin Oncol 23 2005 2763 2771 (Pubitemid 46179466)
49. P.E. Teloken, R.H. Thompson, and S.K. Tickoo Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma J Urol 182 2009 2132 2136
50. B.C. Leibovich, C.M. Lohse, and P.L. Crispen Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma J Urol 183 2010 1309 1315
51. V. Ficarra, M. Brunelli, and L. Cheng Prognostic and therapeutic impact of the histopathologic definition of parenchymal epithelial renal tumors Eur Urol 58 2010 655 668
52. M. Meskawi, M. Sun, and Q.D. Trinh A review of integrated staging systems for renal cell carcinoma Eur Urol 62 2012 303 314
53. H. Isbarn, and P.I. Karakiewicz Predicting cancer-control outcomes in patients with renal cell carcinoma Curr Opin Urol 19 2009 247 257
54. P.I. Karakiewicz, N. Suardi, and U. Capitanio Conditional survival predictions after nephrectomy for renal cell carcinoma J Urol 182 2009 2607 2612
55. H. Moch, J.C. Presti Jr., and G. Sauter Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma Cancer Res 56 1996 27 30 (Pubitemid 26010380)
56. K. Junker, P. Moravek, and M. Podhola Genetic alterations in metastatic renal cell carcinoma detected by comparative genomic hybridization: correlation with clinical and histological data Int J Oncol 17 2000 903 908
57. F.A. Monzon, K. Alvarez, and L. Peterson Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis Mod Pathol 24 2011 1470 1479
58. T. Klatte, P.N. Rao, and M. de Martino Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma J Clin Oncol 27 2009 746 753
59. J. Sanjmyatav, K. Junker, and S. Matthes Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinoma J Urol 186 2011 2078 2083
60. Q. Zhang, J. Ying, and J. Li Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, is associated with more advanced tumor stage J Urol 184 2010 731 737
61. M.A. Hildebrandt, J. Gu, and J. Lin Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma Oncogene 29 2010 5724 5728
62. J. Heinzelmann, B. Henning, and J. Sanjmyatav Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma World J Urol 29 2011 367 373
63. H.W. Khella, N.M. White, and H. Faragalla Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses Tumour Biol 33 2012 131 140
64. S. Osanto, Y. Qin, and H.P. Buermans Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing PLoS One 7 2012 e38298
65. J. Lin, Y. Horikawa, P. Tamboli, J. Clague, C.G. Wood, and X. Wu Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma Carcinogenesis 31 2010 1805 1812
66. N.P. van Erp, K. Eechoute, and A.A. van der Veldt Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicity J Clin Oncol 27 2009 4406 4412
67. A.A. van der Veldt, K. Eechoute, and H. Gelderblom Genetic polymorphisms associated with a prolonged progression-free survival in patients with metastatic renal cell cancer treated with sunitinib Clin Cancer Res 17 2011 620 629
68. J. Garcia-Donas, E. Esteban, and L.J. Leandro-Garcia Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study Lancet Oncol 12 2011 1143 1150
69. C.F. Xu, N.X. Bing, and H.A. Ball Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes J Clin Oncol 29 2011 2557 2564